These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 37382423)
1. Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward. Habibi S; Rashidi A Gut Microbes; 2023; 15(1):2229567. PubMed ID: 37382423 [TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585 [TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics. Gray AN; DeFilipp Z Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290 [TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature. Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171 [TBL] [Abstract][Full Text] [Related]
5. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut]. Kakihana K Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766 [TBL] [Abstract][Full Text] [Related]
13. Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Wang Y; Zhang S; Borody TJ; Zhang F Chin Med J (Engl); 2022 Aug; 135(16):1927-1939. PubMed ID: 36103991 [TBL] [Abstract][Full Text] [Related]
14. Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial. Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C Clin Cancer Res; 2023 Dec; 29(23):4920-4929. PubMed ID: 37787998 [TBL] [Abstract][Full Text] [Related]
15. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report. Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333 [TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and acute graft-versus-host disease. Yoshioka K; Kakihana K; Doki N; Ohashi K Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475 [TBL] [Abstract][Full Text] [Related]
17. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML. Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C J Clin Oncol; 2023 Dec; 41(34):5306-5319. PubMed ID: 37235836 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease. van Lier YF; Vos J; Blom B; Hazenberg MD Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370 [TBL] [Abstract][Full Text] [Related]